OR WAIT null SECS
March 28, 2025
Video
In this video, part 3 of a 4-part series, panelists discuss the impact of recent approvals and pipeline developments on the outlook for ATTR-CM management.
In this video, part 2 of a 4-part series, panelists discuss on recent advancements in imaging and biomarker-based diagnostics for ATTR-CM
In this video, part 1 of a 4-part series, panelists discuss recent advancements in ATTR-CM management.
March 22, 2025
Article
Our top 5 headlines featured new migraine guidelines, the benefit of automated insulin delivery for type 2 diabetes, and 3 key FDA decisions.
March 21, 2025
The approval expands the indication for vutrisiran, which becomes the first therapeutic approved by the FDA for the treatment of ATTR-CM.
March 11, 2025
The regulatory agency granted 510(k) clearance to Caristo Diagnostics' image analysis software to aid in coronary artery disease diagnosis.
March 10, 2025
The regulatory agency accepted the BLA's filing and assigned a target action date of August 31, 2025.
December 31, 2024
To celebrate the close of 2024, we're recapping the 10 most popular approval articles across the HCPLive Network of brands.
December 26, 2024
We spotlight 5 impactful regulatory decisions scheduled to occur during the first quarter of 2025.
This listicle highlights 5 major approvals and 5 trial updates in cardiovascular care from 2024.
